Patent Assignment
Reel/Frame 037766/0669
Assignment of Assignor's Interest
Recorded: 2016-02-18
Pages: 9
Assignors
SPENCER, DAVID M.
Executed: 2016-01-05
FOSTER, AARON EDWARD
Executed: 2016-01-08
BAYLE, JOSEPH HENRI
Executed: 2016-01-05
SLAWIN, KEVIN M.
Executed: 2016-01-05
COLLINSON-PAUTZ, MATTHEW R.
Executed: 2016-01-06
Assignee
BELLICUM PHARMACEUTICALS, INC.
2130 WEST HOLCOMBE BLVD., SUITE 800, HOUSTON, TEXAS, 77030
Covered Property
(1)
Methods for Controlled Elimination of Therapeutic Cells
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 1, 2020
From: BELLICUM PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 052284/0113 →
Release of Security Interest
Nov 3, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 054295/0946 →
Assignment of Assignor's Interest
Feb 21, 2024
From: BELLICUM PHARMACEUTICALS, INC.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 066643/0549 →